Cocrystal Pharma Inc. logo

Cocrystal Pharma Inc.

COCP | NASDAQ
Chart Builder DCF Calculator
$1.22
+$0.01 (+0.83%)
At close: Sep 21, 2026, 3:59 PM ET
$1.19
-$0.03 (-2.46%)
After-hours: Sep 21, 2026, 4:10 PM ET
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
330K 225K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 510K 999K 1.55M
Cost of Revenue
-349K -328K 941K 2.36M 4.65M 8.94M 10.53M 14.77M 15.72M 14.21M 15.17M 14.19M 13.87M 13.43M 12.39M 9.2M 7.44M 7.63M 6.34M 6.94M 6.91M 6.33M
Gross Profit
679K 553K -941K -2.36M -4.65M -8.94M -10.53M -14.77M -15.72M -14.21M -15.17M -14.19M -13.87M -13.43M -12.39M -9.2M -7.44M -7.63M -6.34M -6.43M -5.91M -4.78M
Operating Income
-10.11M -9.03M -9.02M -9.77M -12.72M -16.06M -17.88M -19.31M -18.72M -17.61M -18.56M -18.4M -19.65M -39.74M -38.83M -38.03M -36.29M -15.69M -14.22M -11.99M -10.74M -10.36M
Interest Income
-33K -15K n/a 142K 231K 354K 537K 662K 871K 860K 640K 460K 140K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-9.94M -8.83M -8.83M -9.67M -12.56M -15.85M -17.5M -18.7M -17.93M -16.75M -17.98M -18.02M -19.56M -39.82M -38.84M -38.02M -36.26M -15.66M -14.19M -11.99M -10.72M -10.4M
Net Income
-9.94M -8.83M -8.83M -9.67M -12.56M -15.85M -17.5M -18.7M -17.93M -16.75M -17.98M -18.02M -19.56M -39.82M -38.84M -38.02M -36.26M -15.66M -14.19M -11.99M -10.72M -10.4M
Selling & General & Admin
4.35M 4.19M 3.96M 4.27M 4.93M 5.09M 5.31M 5.55M 5.6M 5.99M 5.99M 5.81M 5.78M 5.62M 5.75M 5.93M 5.95M 5.85M 5.68M 5.56M 4.83M 5.59M
Research & Development
6.09M 5.07M 5.06M 5.47M 7.76M 10.95M 12.54M 14.77M 15.72M 14.21M 15.17M 14.19M 13.87M 13.43M 12.39M 11.31M 9.55M 9.74M 8.45M 6.94M 6.91M 6.33M
Other Expenses
349K 328K -941K -2.34M -4.62M -8.91M -10.5M -15.77M -18.32M -16.81M -17.77M -15.79M -13.87M 7.27M 8.3M 11.59M 13.35M -7.53M -6.24M -6.94M -6.91M -6.33M
Operating Expenses
10.79M 9.59M 8.08M 7.41M 8.07M 7.12M 7.35M 4.55M 3M 3.39M 3.39M 4.21M 5.78M 26.31M 26.44M 28.83M 28.85M 8.06M 7.89M 5.56M 4.83M 5.59M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 78K 79K 80K 80K 3K 2K 2K 4K 4K 6K 7K 7K
Selling & Marketing Expenses
n/a n/a 39K 39K 39K 39K 55K 55K 55K 55K 22K 22K 22K 22K 19K 19K 19K 19K 19K -35K -35K -35K
Cost & Expenses
10.44M 9.26M 9.02M 9.77M 12.72M 16.06M 17.88M 19.31M 18.72M 17.61M 18.56M 18.4M 19.65M 39.74M 38.83M 38.03M 36.29M 15.69M 14.22M 12.5M 11.74M 11.92M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
13.79M 13.79M 11.29M 10.99M 10.17M 10.17M 10.17M 10.17M 10.17M 10.17M 10.17M 10.15M 10.07M 8.14M 8.14M 8.14M 8.12M 8.12M 7.26M 8.12M 7.26M 5.94M
Shares Outstanding (Diluted)
13.79M 13.79M 11.29M 10.99M 10.17M 10.17M 10.17M 10.17M 10.17M 10.17M 10.17M 10.15M 10.07M 8.14M 8.14M 8.14M 8.12M 8.12M 7.26M 8.14M 7.26M 5.94M
EPS (Basic)
-0.77 -0.74 -0.80 -0.94 -1.24 -1.57 -1.73 -1.85 -1.77 -1.65 -1.91 -2.02 -2.31 -7.45 -7.32 -7.28 -7.07 -2.05 -1.99 -1.79 -1.86 -2.13
EPS (Diluted)
-0.77 -0.74 -0.80 -0.94 -1.24 -1.57 -1.73 -1.85 -1.77 -1.65 -1.91 -2.02 -2.31 -7.45 -7.32 -7.28 -7.06 -2.04 -1.98 -1.78 -1.86 -2.13
EBITDA
-9.49M -8.39M -8.46M -9.36M -12.46M -15.73M -17.38M -19.77M -20.85M -19.66M -20.8M -19.62M -19.29M -18.86M -17.96M -17.09M -15.33M -15.41M -13.94M -11.78M -10.55M -10.19M
EBIT
-9.94M -8.83M -8.83M -9.67M -12.56M -15.85M -17.5M -19.9M -21.01M -19.83M -20.99M -19.82M -19.48M -19.05M -18.14M -17.33M -15.57M -15.65M -14.18M -11.96M -10.73M -10.36M
Depreciation & Amortization
445K 442K 376K 313K 104K 116K 126K 138K 161K 175K 189K 197K 191K 188K 185K 234K 237K 240K 239K 187K 181K 172K

© 2026 bestshares.com. All rights reserved.